$36.540
+0.943 (+2.58%)At close
DBX News
DBX Events
Major Averages Finish Near Flatline, Tech Stocks Weighed Down by Oracle
The major averages spent the morning in the red, but stocks pared losses later in the day and the S&P 500, Dow, and Nasdaq 100 finished not far from the flatline. Reports suggested that U.S. and Iranian negotiators were closer to agreeing on restoring tanker flows through the Strait of Hormuz, easing fuel prices and yields on shorter-dated maturities. A drop in Oracle shares weighed on the broader tech sector, balanced by renewed AI optimism following Meta's Muse product rollout event.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Metaannounced a series of new products, including Meta VR glasses, the Muse Charm device, and its first line of audio glassesQualcommrenewed its global patent license agreement with AppleStarbuckssaid it will close 250 coffeehouses later this weekDardenreported mostly in-line Q1 results and reiterated its FY27 earnings outlookPeople Incorporatedwithdrew its takeover bid for MGM Resorts, saying it "didn't feel the mix was coming together"2. WALL STREET CALLS:Alkamidouble downgraded to Underweight from Overweight at JPMorganJPMorgan upgraded CoreWeaveto Overweight on strong demandCiti downgraded Dropboxto Sell with too much AI success priced inDollar Generalupgraded to Buy at HSBC on recovery progressArgus cut Yum! Brandsto Hold on headwinds to profit target3. AROUND THE WEB:UBSis weighing a merger to relocate out of Switzerland, Semafor reportsGoldman Sachsearned more than $200M from AI hedge fund Situational Awareness, FT reportsAlibabais accelerating its data center expansion in Europe and the Middle East as part of its global infrastructure buildout, Bloomberg reportsHondais in advanced discussions to build a hybrid vehicle plant in the U.S. for $1.8B-$2.5B, Nikkei Asia saysAmazonwill spend $3B to grow its quick-commerce business in India by 2030, Reuters reports4. MOVERS:Everpuregained after backing its guidance for FY27 and providing its outlook for FY28Grailincreased after FDA advisors voted to recommend approval for its Galleri cancer testNebiuswas higher after BNP Paribas upgraded the stock to OutperformOraclefell after Bloomberg reported the company sent Blue Owl Capital, the developer of its data center being built in New Mexico, a notice citing force majeureAppLovinand Robloxwere lower after Metaannounced Horizon Create and Horizon Studio, two new AI-powered tools that allow users to create complete 2D and 3D mobile games5. EARNINGS/GUIDANCE:BlackBerryreported Q2 results and provided guidance for Q3 and FY27Trio-Techreported Q4 results, with EPS lower year-over-yearDucommunreaffirmed its outlook for FY26TransUnionbacked its outlook for Q3 and FY26H.B. Fullerreported Q3 results, with EPS beating consensusINDEXES:The Dow fell 161.61, or 0.31%, to 51,349.98, the Nasdaq gained 3.34, or 0.01%, to 26,939.37, and the S&P 500 declined 1.90, or 0.02%, to 7,704.13.
Major Averages Decline for Second Day, Oil Prices Surge Nearly 4%
The major averages were broadly lower for a second day in a row and Treasury yields kept climbing with investors expecting further rate hikes from the Fed. A drop in Oracle shares also weighed on the broader tech sector even amid renewed AI optimism following Meta's Muse product rollout event. Meanwhile, oil prices surged nearly 4% amid continued tensions in the Middle East.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Metaannounced a series of new products, including Meta VR glasses, the Muse Charm device, and its first line of audio glassesQualcommrenewed its global patent license agreement with AppleStarbuckssaid it will close 250 coffeehouses later this weekDardenreported mostly in-line Q1 results and reiterated its FY27 earnings outlookPeople Incorporatedwithdrew its takeover bid for MGM Resorts, sayin git "didn't feel the mix was coming together"2. WALL STREET CALLS:Alkamidouble downgraded to Underweight from Overweight at JPMorganJPMorgan upgraded CoreWeaveto Overweight on strong demandCiti downgraded Dropboxto Sell with too much AI success priced inDollar Generalupgraded to Buy at HSBC on recovery progressArgus cut Yum! Brandsto Hold on headwinds to profit target3. AROUND THE WEB:Alibabais accelerating its data center expansion in Europe and the Middle East as part of its global infrastructure buildout, Bloomberg reportsHondais in advanced discussions to build a hybrid vehicle plant in the U.S. for $1.8B-$2.5B, Nikkei Asia saysAmazonwill spend $3B to grow its quick-commerce business in India by 2030, Reuters reportsOraclesent Blue Owl Capital, the developer of its data center being built in New Mexico, a notice citing force majeure, Bloomberg saysMorgan Stanleyis working to contain the damage from its leaked deal list, Bloomberg reports4. MOVERS:Everpuregains after backing its guidance for FY27 and providing its outlook for FY28Grailincreases after FDA voted to recommend approval for its GalleriNebiushigher in New York after BNP Paribas upgraded the stock to OutperformTD Synnexfalls after reporting Q3 results and providing guidance for Q4Viking Therapeuticslower after announcing a 7.86M share offering5. EARNINGS/GUIDANCE:BlackBerryreported Q2 results and provided guidance for Q3 and FY27Trio-Techreported Q4 results, with EPS lower year-over-yearDucommunreaffirmed its outlook for FY26TransUnionbacked its outlook for Q3 and FY26H.B. Fullerreported Q3 results, with EPS beating consensusINDEXES:Near midday, the Dow was down 335.02, or 0.65%, to 51,176.57, the Nasdaq was down 193.11, or 0.72%, to 26,742.93, and the S&P 500 was down 36.55, or 0.47%, to 7,669.48.
Stock Futures Decline as Treasury Yields Rise
Stock futures have slumped Thursday as a sharp rise in Treasury yields and renewed oil price gains weighed on equities, more than offsetting renewed AI optimism following Meta'sMuse product rollout event.In pre-market trading, S&P 500 futures declined 0.5%, Nasdaq 100 futures fell 0.95% and Dow futures lost 0.26%.Check out this morning's top movers from around Wall Street, compiled by The Fly.HIGHER -Knife Riverup 5% following Starboard Value announcing a position and plans to push the company's management to improve its margins or explore a saleEverpureup 6% after the company forecast revenue for 2028 that exceeded estimatesDolby Labsup 4% after the company announced the expansion of Dolby experiences within the Meta ecosystem of devices and platformsUP AFTER EARNINGS -H.B. Fullerup 1%BlackBerryup 1%DOWN AFTER EARNINGS -Stitch Fixdown 17%Dardendown 4%TD Synnexdown 10%LOWER -MGM Resortsdown 10% after Barry Diller's Peopledropped plans to acquire the rest of the casino company it does not already ownDropboxdown 5% after Citi downgraded the stock to SellEtsydown 2% after Arete downgraded the stock to Neutral from BuyViking Therapeuticsdown 12% after offering $200M in common shares and another $200M in convertible notes to help fund clinical developmentAcadia Pharmaceuticalsdown 5% after saying its Phase 2 portion of RADIANT trial "narrowly missed" its primary endpoint
Stock Futures Mixed as Doximity Soars 83.93%
Stock futures were mixed following a mostly lower regular session as investors continue to digest another round of corporate earnings and await news out of the Middle East.Economic data remains a central focus ahead of Friday's July employment report. Markets remain divided over the Federal Reserve's next policy move, with incoming employment data expected to play an important role in shaping expectations for interest rates over the coming months.Check out this evening's top movers from around Wall Street, compiled by The Fly.HIGHER AFTER EARNINGS -Doximityup 83.93%Atlassianup 32.1%Figsup 24.6%QuinStreetup 23%Cloudflareup 16.9%Twilioup 16.7%Nateraup 15.3%Akamaiup 13%Airbnbup 10.3%Instacartup 9%ALSO HIGHER -DoubleVerifyup 13.2% after Nielsen agreed to acquire the company in an all-cash transaction valued at roughly $2.15BDOWN AFTER EARNINGS -Trade Deskdown 24.5%QuidelOrthodown 21.8%Xponential Fitnessdown 12.9%Cable Onedown 9.5%Maravai Lifesciencesdown 8.8%ResMeddown 5.9%10x Genomicsdown 4.7%Dropboxdown 4.1%Post Holdingsdown 3%
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.









